financing

News

Which biotechs have raised new VC financing this week?

Our latest roundup of financings in the biotech sector includes solid eight-figure rounds for Triveni, Cellares, HMNC, Vedana, and Neion Bio.

News

Heart drug biotech Kardigan raises $400m in upscaled IPO

Cardiovascular drug developer Kardigan has completed its IPO, raising substantially more than it originally anticipated.

News

SonoThera's $125m Series B heads recent biofinancings

Our latest roundup of financings in the biotech sector includes impressive rounds for SonoThera, Ethyreal, CeQur, and City Therapeutics.

News

Cancer biotech Parabilis books record IPO, raising $670m

Parabilis has broken the IPO record set by Kailera in April, packing its coffers as it starts an ambitious trial programme for lead drug zolucatetide.

News

Parabilis prices IPO at an ambitious $475 million

Parabilis has set the terms of its IPO, seeking to raise a hefty $475m for phase 3 trials of its lead drug for desmoid tumours.

News

Analogue alarm clock with three piles of gold coins and plant shoot growing from them

NewLimit raises $435m for liver trials, and other financings

Longevity biotech NewLimit's $435m Series C heads this week's round-up of biotech venture capital financings.

Which biotechs have raised new VC financing this week?

Heart drug biotech Kardigan raises $400m in upscaled IPO

SonoThera's $125m Series B heads recent biofinancings

Cancer biotech Parabilis books record IPO, raising $670m

Parabilis prices IPO at an ambitious $475 million

NewLimit raises $435m for liver trials, and other financings

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

financing

Editor's Picks